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ABSTRACT 
 
The ICES biological effects monitoring in pelagic ecosystems (BECPELAG) workshop is a 
multi-national, multi-disciplinary workshop aimed at establishing suitable techniques for 
monitoring the effects of contaminants on pelagic ecosystems. One of the many activities that 
have been performed concurrently is the extraction of water samples using semi-permeable 
membrane devices (SPMDs) and large volume solid phase extraction (SPE) followed by in 
vitro testing and targeted chemical analysis of the concentrated extracts. The following in 
vitro assays were used: DR-CALUX, yeast oestrogen and androgen screen (YES & YAS), 
blue mussel (Mytilus edulis) embryo, Tisbe battagliai, and Skeletonema costatum. Data from 
the study are presented along with recommendations on procedures for the use of in vitro in 
the monitoring of the pelagic environment. 
 
Keywords: In vitro bioassays, solid phase extraction, contaminant concentration, semi-
permeable membrane devices, produced water. 
 
 
INTRODUCTION 
 
High quality data on the health of marine pelagic ecosystems are required for the successful 
environmental management of any activity that has the potential to have an adverse effect. 
The ICES biological effects monitoring in pelagic ecosystems (BECPELAG) workshop is a 
multi-national, multi-discipline workshop aimed at establishing suitable techniques for 
monitoring the effects of contaminants on pelagic ecosystems. The main objective of the 
workshop is to assess the ability of selected methods to detect biological effects of 
xenobiotics in pelagic systems. In addition, the results from the workshop will be used as a 
basis to suggest methods for future monitoring of biological effects in pelagic systems. 
 
One of the many activities that have been performed concurrently is the extraction of water 
samples using semi-permeable membrane devices (SPMDs) and large volume solid phase 
extraction (SPE) followed by in vitro testing and targeted chemical analysis of the 
concentrated extracts. The following in vitro bioassays were used: DR-CALUX (aryl 
hydrocarbon receptor), yeast oestrogen and androgen screen (YES & YAS), blue mussel 
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(Mytilus edulis) embryo, Tisbe battagliai, and Skeletonema costatum. All these assays are 
suitable for the testing of concentrated extracts since they require low sample volumes (< 20 
ml), need minimal space and equipment for testing, are sensitive and have easily determined 
end-points. 
 
In this paper we describe the sampling of produced and surface water samples from the North 
Sea, their extraction and subsequent testing using the in vitro bioassays described above.  
 
 
METHODS 
Sample locations 
During the workshop eight sample locations were used along two transects; one in the 
German Bight and one in the Statfjord area within the Norwegian sector of the North Sea 
(Table 1). 
 
Water Sampling 
Water samples (50 L) were collected in an alloy churn sampler designed to take discrete 
water samples at a selected depth (1 m for GB and 10 m for the Statfjord area).  Samples were 
collected from both areas during June 2001. SPMDs were placed at the same locations for 6 
weeks during the same period. 
 
Solid phase extraction (SPE) 
The general approach used for the extraction of water samples has been previously described 
(Thomas et al., 1999a; Thomas et al., 1999b). Typically, a 100 L water sample was forced, 
using compressed air, through a Teflon column packed with glass wool (previously rinsed 
with acetone and dried) and a octylsilane (C18; 5 g; IST, Hengoed, UK) and polystyrene-
based polymer Isolute ENV+ solid phase extraction cartridges (1 g; IST, Hengoed, UK) 
connected in series. The SPE columns were then dried under vacuum, extracted using 
methanol (10 ml) and then dichloromethane (DCM; 10 ml), combined, reduced in volume to 
5 ml in methanol and stored at -20ºC. 
 
Semi Permeable Membrane Devices (SPMDs) 
SPMDs were deployed and extracted as described by Huckins et al. (1995). Extracts in DCM 
were stored at -20ºC prior to testing. 
 
Bioassays  
A suite of small scale bioassays was employed using published methods: Tisbe battagliai 
(mortality; Thomas et al.,1999a), blue mussel (Mytilus edulis) embryo (larval formation; 
ASTM, 1993), Skeletonema costatum (growth inhibition; ISO, 1994), DR-CALUX (rat aryl 
hydrocarbon receptor, AhR; Murk et al., 1996), yeast oestrogen and androgen screen (YES & 
YAS, human oestrogen and androgen receptor, Routledge & Sumpter, 1996; Sohoni and 
Sumpter, 1998).  
 
Chemical analyses 
SPMD and SPE extracts were analysed for alkylphenols (APs) and polycyclic aromatic 
hydrocarbons (PAHs) by the Norwegian Institute for Marine Research (Bergen, NO). 
 
 
RESULTS  
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Results from the bioassay testing of the SPE and SPMD extracts are presented in Table 2 and 
3 respectively. 
  
SPE extracts of surface waters 
None of the surface water SPE extracts, even when concentrated x 103, were lethally toxic to 
the marine copepod T. battagliai. Only one SPE extract inhibited the growth of the diatom S. 
costatum (SF03), whilst blue mussel larval deformities were observed in extracts obtained 
from GB02, GB04, SF02, SF04 and UK01. These samples had to be concentrated between 
268 and 793 times before abnormalities were observed in 50% of the organisms tested. With 
the exception of the sample collected at GB02 the presence of in vitro oestrogen receptor 
(ER) agonists were detected in all of the extracts tested (0.007-0.3 ng E2 L-1). No response 
from in vitro androgen receptor (AR) agonists was determined in any of the extracts tested (< 
0.01 ng DHT L-1). With the exception of the sample collected at GB04 in vitro AhR agonists 
were determined in all of the surface water samples collected. 
 
SPE extracts of produced water 
A positive response was obtained in all the bioassays used to test produced water extracts 
apart for the YAS assay (in vitro AR agonists) which the response was below the limit of 
detection of the method (Table 2). 
 
SPMD extracts 
Only aryl hydrocarbon receptor (AhR) agonist activity was determined in the SPMD extracts 
tested (Table 3). 
 
Chemical analysis 
A summary of the targeted chemical analysis of PAHs and APs, as performed by IMR, NO, is 
presented in Table 4. 
 
 
DISCUSSION 
The concentration of contaminants in offshore environments is generally below the detection 
limits of standard bioassays. The extraction and concentration of organic contaminants allows 
the contaminant burden of a sample to be tested, and both spatial and temporal trends to be 
established. In this study, none of the surface water samples tested were toxic to T. battagliai 
and only a few inhibited S. costatum growth even when concentrated x 103. However, 
previous CEFAS studies in coastal and offshore areas have demonstrated that the T. battagliai 
survival and S. costatum growth inhibition tests are suitable for use in this context with 
temporal and spatial data obtained around the UK over the period 1999-2002 (CEFAS, 
Unpublished data). Testing the toxicity of the extracts to blue mussel embryos resulted in a 
response in all but one of the samples tested. This suggests that the combination of sample 
extraction and testing using bivalve embryos may be a promising tool for marine pelagic 
monitoring. Testing surface water extracts with the YES and YAS assays was successful in 
determining the in vitro ER, AR and AhR activities of offshore surface waters. 
Unsurprisingly, low levels of ER activity were measured, whilst the levels of AR activity 
were below that of the method. The in vitro AhR activity of the total SPE extracts were 
determined after 24h using the DR-CALUX assay and show measurable activities in all of the 
samples measured except the sample collected at GB04. Data from the YES and DR-CALUX 
assays will therefore allow an assessment of likely trends to be made when applied on a much 
broader scale. 
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Toxicity assessment of the produced water from two oil production platforms in the Northern 
North Sea allowed the toxic contribution from these effluents to be determined. Extraction 
and concentration of the produced water collected was necessary before effects could be 
measured using the assays deployed. The mussel embryo bioassay was the most sensitive of 
the acute bioassays used with samples collected from SFC demonstrating levels of toxicity of 
between 0.25 and 1 TU representing toxicity at concentrations observed in the original 
produced water. The most sensitive in vitro receptor based assay was for ER activity, 
followed by AhR activity, whilst the AR activity was below the detection limit of the method. 
 
Since produced water contains a complex mixture of chemicals, it is not clear as to which 
chemicals are likely to be causing the effects measured. The most likely compounds to be 
responsible for ER and AhR activities are APs & PAHs respectively (Table 4). However, 
further confirmatory studies are necessary, such as the application of toxicity identification 
evaluation (TIE) procedures, since there is always the possibility of other unknown 
compounds contributing to the overall activity. 
 
A limitation of the sampling design adopted for the SPE extraction as part of this study is that 
the samples only represent a 'snapshot' at the time of the sampling event. The SPMDs 
deployed for a six-week period at the same locations offer a time-integrated sample that can 
be tested using the same assays. From the bioassay data it appears that the SPMDs 
accumulated only AhR agonists during this period (Table 3). For all the benefits that 
integrated sampling SPMDs offer, further work is required to ensure that they accumulate the 
target compounds of choice (e.g. a system suitable for the accumulation of ER agonists) and 
that performance reference compounds (PRCs) are used in order to calculate the average 
concentration of accumulated contaminants in the environment that they are deployed. An in 
situ integrated approach to SPE may also yield benefits in this area.  
 
 
 
CONCLUSIONS 
• The combination of sample extraction and concentration using SPE/SPMDs with in vitro 
testing is a technique that is suitable for determining the ecotoxicological effects of 
marine pelagic ecosystems and point source discharges. 
• In vitro ER and AhR agonist activity can be detected using these techniques in offshore 
surface waters. 
• The produced waters sampled contain compounds that are toxic to blue mussel embryos. 
• The produced waters sampled contain ER and AhR agonists. 
• It is recommended that integrated SPE is combined with SPMDs in future applications of 
this approach.  
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Table 1.  Positions of stations used for ICES BECPELAG workshop 
 
Station Position (Lat Long) 
GB01  54.083 °N, 7.833 °E 
GB02  54.178 °N, 3 7.43°E 
GB03  5.00 °N, 6.325 °E 
GB04  55.38 °N, 4.50 °E 
SF01  61,12,3 °N, 01,50,6 °E 
SF02  61,11,8 °N, 01,52,1 °E 
SF03  61,10,0 °N, 01,59,5 °E 
SF04  60,07,0 °N, 03,03,0 °E 
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Table 2. Summary of the bioassay tests conducted on solid phase extraction (SPE) extracts as part of the BECPELAG workshop 
Station Tisbe battagliai Skeletonema 
costatum 
Mytilus edulis In vitro ER agonist 
potency2 
In vitro AR agonist 
potency3 
In vitro AhR agonist 
potency4 
LC50  TU1 EC50 TU1 EC50 TU1 ng E2 L-1 ng DHT L-1 TCDD TEQ (pg L-1) 
GB01 >1000 < 0.001 >1000 < 0.001 >1000 <0.001 0.007 <0.01 12 (1) 
GB02 >1000 < 0.001 >1000 < 0.001 408 0.002 <0.0007 <0.01 9 (0.3) 
GB04 >1000 < 0.001 >1000 < 0.001 730 0.001 0.01 <0.01 < 1 
SF02 >1000 < 0.001 >1000 < 0.001 793 0.001 - <0.01 30 (1) 
SF03 >1000 < 0.001 288 0.003 - - 0.07 <0.01 170 (6) 
SF04 >1000 < 0.001 >1000 < 0.001 325 0.003 0.3 <0.01 13 (1) 
SFC PW1 67 0.015 31 0.032 4 0.25 23 <0.01 630 (19) 
SFC PW2 75 0.013 13 0.077 2 0.5 24 <0.01 34 (1) 
SFC PW3 54 0.019 - - 1 1 28 <0.01 88 (1) 
UK 01 >1000 < 0.001 >1000 < 0.001 - - 0.04 <0.01 135 (4) 
UK PW 1 945 0.001 >1000 < 0.001 - - 5 <0.1 65 (3) 
UK PW 2 518 0.002 >1000 < 0.001 268 0.004 3 <0.1 38 (0.5) 
  
1 1 TU (Toxic Unit) = 1/EC50 concentration factor. 2 Determined using the yeast oestrogen screen (YES) and expressed as the equivalent 
concentration of 17β-oestradiol to give the same response. 3 Determined using the yeast androgen screen (YAS) and expressed as the equivalent 
concentration of 5α-dihydrotestosterone to give the same response. 4 Determined using the DR-CALUX assay and expressed as 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) TEQ. 
 
Table 3. Bioassay test results conducted on the SPMD extracts as part of the BECPELAG workshop 
Station In vitro ER agonist potency  
(ng E2 Kg lipid-1)1 
In vitro AR agonist potency  
(ng DHT Kg lipid-1)2 
In vitro AhR agonist potency  
(pg TCDD TEQ mg lipid-1)3 
GB01   <149 <394 2
GB02    
    
    
    
    
<168 <447 1
GB03 <89 <236 1
GB04 <172 <458 <0.4
SF01 <70 <188 4
SF04 <41 <108 0.5
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1 Determined using the yeast oestrogen screen (YES) and expressed as the equivalent concentration of 17β-oestradiol to give the same response. 2  
Determined using the yeast androgen screen (YAS) and expressed as the equivalent concentration of 5α-dihydrotestosterone to give the same 
response. 4 Determined using the DR-CALUX assay and expressed as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) TEQ. 
 
Table 4a. Alkylphenol concentrations present in the SPE samples collected as part of the BECPELAG workshop. 
Station Total sum of alkylphenols (µg L-1) 
 C
           
1 C2 C3 C4 C5 C6 C7 C8 C9 Total (C1-9) 
GB01 1.2 2.8 1.9 0.9 0.7 0.2 0.0 0.3 0.4 8.4
SF02           
           
           
           
           
           
0.7 0.8 0.7 0.3 0.2 0.1 0.0 0.1 0.2 3.0
SF03 0.7 0.9 0.5 0.2 0.1 0.0 0.3 0.1 0.0 2.8
SF04 1.2 2.1 2.1 0.9 0.8 0.2 0.3 0.2 0.3 8.2
SFC01 37.4 67.0 26.9 18.6 13.0 3.7 0.2 6.0 9.3 182.2
SFC02 68.6 1103.4 73.7 64.7 88.2 21.5 0.8 15.4 32.7 1468.9
SFC03 2.1 2.4 1.1 0.6 0.5 0.1 0.0 0.2 0.4 7.3
 
 
Table 4b. Polycyclic aromatic hydrocarbon concentrations in the SPE samples collected as part of the BECPELAG workshop 
 Polycyclic aromatic hydrocarbons (µg L-1) 
 Naphthalene & Alkyl Na 
  C  
Phenanthrene & Alkyl Phe 
 C  
Dibenzothiophene & Alkyl Dthio 
 C  
Flu Pyr 
Sample
 
 C C C   
              
N C1 2 3 1 C2 3 1 C2 3 
GB01 0.08 0.12 0.19 0.18 0.08 0.10 0.05 0.02 0.04 0.03 0.13 0.01 0.01 0.02
GB02               
               
               
               
               
               
               
0.12 0.14 0.12 0.10 0.04 0.06 0.06 0.01 0.02 0.01 0.05 0.01 0.01 0.01
SF02 0.16 0.26 0.85 0.75 0.42 1.66 2.26 1.33 0.07 0.27 0.17 0.32 0.28 1.05
SF03 0.10 0.08 0.10 0.01 0.05 0.07 0.01 0.01 0.02 0.02 0.02 0.00 0.00 0.00
SF04 0.15 0.31 1.01 0.37 0.45 1.60 1.98 1.12 0.08 0.25 0.23 0.29 0.30 1.00
SFC01 0.22 0.25 0.23 0.16 0.05 0.08 0.05 0.02 0.03 0.02 0.04 0.01 0.01 0.02
SFC02 252 81.5 59.4 20.5 5.27 12.6 10.5 3.02 2.19 4.29 1.60 0.17 0.40 0.73
SFC03 790 834 356 99.0 13.4 11.5 9.09 2.20 5.90 5.37 6.74 4.25 0.48 0.75
Na- napthalene, Phe- phenanthrene, Dthio- dibenzothiophene, Flu- fluoranthene, Pyr- pyrene. 
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Table 4b (cont.) 
 Polycyclic aromatic hydrocarbons (µg L-1) 
Sample      
             
Ay Ace Flu Anth  BaA Chr
 
BbjkF BeP BaP Per IdP DbA Bghi
GB01 - - 0.04 0.01 - - - - - - - - -
GB02             
    
              
    
             
       
       
- - 0.01 - - - - - - - - - -
SF02 0.01 0.01 0.12 0.01 0.02 0.18 0.06 0.20 0.11 0.01 0.22 0.02
SF03 - - - - - - - - - - - - -
SF04 0.01 0.01 0.15 0.01
 
 0.01 0.18 0.06 0.20 0.12 0.01 0.34 0.01
SFC01 - - 0.03 - - - - - - - - - -
SFC02 0.85 0.19 3.07 0.04 0.01 0.13 0.01 0.01 - - 0.01 - 0.01
SFC03 1.81 0.69 8.15 0.08 0.01 0.13 - 0.01 - - - - -
Ay- acenaphthylene, Ace- acenaphthene, Flu- fluorene, Anth- anthracene, BaA- benzo[a]anthracene, Chr- chrysene/triphenylene, BbjkF- 
benzo[bjk]fluoranthene, BeP- benzo[e]pyrene, BaP- benzo[a]pyrene, Per- perylene, IdP- indeno[1,2,3-cd]pyrene, DbA- dibenz[a,h]anthracene, 
Bghi- benzo[ghi]perylene. 
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